Toll-like receptor 3 pathway restricts Marek's disease virus infection

被引:14
|
作者
Zou, Haitao [1 ,2 ]
Su, Ruixue [1 ,2 ]
Ruan, Jing [1 ,2 ]
Shao, Hongxia [1 ,2 ,3 ]
Qian, Kun [1 ,2 ,3 ]
Ye, Jianqiang [1 ,2 ,3 ]
Qin, Aijian [1 ,2 ,3 ]
机构
[1] Yangzhou Univ, Key Lab Avian Prevent Med, Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China
[2] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China
[3] Jiangsu Key Lab Zoonosis, Yangzhou 225009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Marek's disease virus; toll-like receptor 3; poly (I:C); interferon-beta; inflammatory cytokines; HERPES-SIMPLEX-VIRUS; INTERFERON-STIMULATED GENES; BETA INTERFERON; VIRAL PATHOGENESIS; KAPPA-B; ACTIVATION; EXPRESSION; IMMUNITY; CELLS; MODEL;
D O I
10.18632/oncotarget.20003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Marek's disease virus (MDV) is an alpha-herpesvirus that causes immune suppression and T lymphoma in chickens. Toll-like receptor 3 (TLR3) is critical for the host immune response against MDV infection. Previously, our team demonstrated that pre-treatment of TLR3 agonist poly (I:C) inhibited Marek's disease virus infection in chicken embryo fibroblasts (CEFs). However, whether TLR3 inhibits the aggravation of MDV infection is unknown. In the current study, we found that TLR3 activation in MDV-infected CEFs effectively inhibited virus spread. Using pharmacological approaches, we revealed that pro-inflammatory cytokines and interferon-beta induced by TLR3 could restrict Marek's disease virus infection. This study contributes to elucidating the function and mechanism of the TLR3 pathway in host immune responses against MDV infection.
引用
收藏
页码:70847 / 70853
页数:7
相关论文
共 50 条
  • [31] Role of Toll-like receptor mediated signaling pathway in ischemic heart
    Takeishi, Yasuchika
    Kubota, Isao
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 2553 - 2558
  • [32] The impact of the absence of Toll-like receptor-2 during Sporothrix brasiliensis infection
    Rossato, Luana
    dos Santos, Suelen Silvana
    Ferreira, Lucas Goncalves
    de Almeida, Sandro Rogerio
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (01) : 87 - 94
  • [33] The Therapeutic Potential of Targeting the Toll-like Receptor Pathway in Breast Cancer
    Toroghian, Younes
    Khayyami, Reza
    Hassanian, Seyed Mahdi
    Nassiri, Mohammadreza
    Ferns, Gordon A.
    Khazaei, Majid
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (27) : 2203 - 2210
  • [34] Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens
    Barjesteh, Neda
    Shojadoost, Bahram
    Brisbin, Jennifer T.
    Emam, Mehdi
    Hodgins, Douglas C.
    Nagy, Eva
    Sharif, Shayan
    VACCINE, 2015, 33 (38) : 4843 - 4849
  • [35] Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease
    Verzola, Daniela
    Bonanni, Alice
    Sofia, Antonella
    Montecucco, Fabrizio
    D'Amato, Elena
    Cademartori, Valeria
    Parodi, Emanuele Luigi
    Viazzi, Francesca
    Venturelli, Chiara
    Brunori, Giuliano
    Garibotto, Giacomo
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (01) : 131 - 144
  • [36] The toll-like receptor 3 pathway in homeostasis, responses to injury and wound repair
    Ramnath, Divya
    Powell, Elizabeth E.
    Scholz, Glen M.
    Sweet, Matthew J.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 61 : 22 - 30
  • [37] Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease
    Palikhe, Nami Shrestha
    Kim, Seung-Hyun
    Kim, Joo-Hee
    Losol, Purevsuren
    Ye, Young-Min
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (02) : 123 - 127
  • [38] Toll-Like Receptor 7 Ligands Inhibit Influenza A Infection in Chickens
    Stewart, Cameron R.
    Bagnaud-Baule, Audrey
    Karpala, Adam J.
    Lowther, Sue
    Mohr, Peter G.
    Wise, Terry G.
    Lowenthal, John W.
    Bean, Andrew G.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (01) : 46 - 51
  • [39] Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling
    Garcia-Cattaneo, Alejandra
    Gobert, Francois-Xavier
    Mueller, Melanie
    Toscano, Florent
    Flores, Marcella
    Lescure, Aurianne
    Del Nery, Elaine
    Benaroch, Philippe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (23) : 9053 - 9058
  • [40] Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy
    Zou, Jia-Nan
    Xiao, Jing
    Hu, Sha-Sha
    Fu, Chen-Sheng
    Zhang, Xiao-Li
    Zhang, Zhen-Xing
    Lu, Yi-Jun
    Chen, Wei-Jun
    Ye, Zhi-Bin
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 906 - 913